Results 71 to 80 of about 4,326 (212)

Classifying cognitive status with TabCAT Match and UDS executive function tests

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Tablet‐based Cognitive Assessment Tool (TabCAT) Match, a digital neuropsychological test, was compared to measures of executive function from the National Alzheimer's Coordinating Center's Uniform Dataset (UDS). METHODS TabCAT Match data were available for 1792 clinically diverse older adults.
Alexandra J. Weigand   +9 more
wiley   +1 more source

Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia

open access: yesFrontiers in Neurology, 2019
Background: While primary progressive aphasia (PPA) is associated with frontotemporal lobar degeneration (FTLD) pathology due to tau or TDP, clinical-pathological studies also demonstrate many cases have Alzheimer's disease (AD) pathology.
Catherine Norise   +7 more
doaj   +1 more source

Word-finding pauses in primary progressive aphasia (PPA): Effects of lexical category [PDF]

open access: yes, 2013
Word-finding pauses are common in logopenic primary progressive aphasia (PPA-L). However, no previous research investigated the distribution of word-finding pauses in PPA or their specificity to PPA-L.
Dove, Sarah   +5 more
core  

Establishing two principal dimensions of cognitive variation in logopenic progressive aphasia [PDF]

open access: yesBrain Communications, 2019
Abstract Logopenic progressive aphasia (LPA) is a neurodegenerative syndrome characterised by sentence repetition and naming difficulties arising from left-lateralised temporoparietal atrophy. Clinical descriptions of LPA largely concentrate on profiling language deficits, however, accumulating evidence points to the presence of ...
Ramanan, Siddharth   +6 more
openaire   +2 more sources

How artificial intelligence is shaping neuropsychology: A focus on cognitive assessment of neurodegenerative disorders

open access: yesJournal of Neuropsychology, Volume 20, Issue 1, Page 256-275, March 2026.
Abstract Artificial intelligence (AI) and machine learning (ML) algorithms are revolutionising the world, and they have the potential to revolutionise neuropsychology as well. A particularly fruitful field for this revolution is the cognitive assessment of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Mild Cognitive ...
Michele Scandola   +3 more
wiley   +1 more source

Noun and Verb Production and Comprehension in Stroke-Induced and Primary Progressive Aphasia: An Introduction to the Northwestern Naming Battery [PDF]

open access: yes, 2011
This study examined production and comprehension of nouns and verbs using the Northwestern Naming Battery (NNB), a new test designed to assess naming ability in individuals with stroke-induced or primary progressive aphasia (PPA). Scores derived from the
King, Monique C.   +3 more
core  

Screening for Aphasia in NeuroDegeneration for the Diagnosis of Patients with Primary Progressive Aphasia: Clinical Validity and Psychometric Properties. [PDF]

open access: yes, 2018
BACKGROUND: We evaluated the psychometric proprieties of the Screening for Aphasia in NeuroDegeneration (SAND) battery in Italian primary progressive aphasia (PPA) and movement disorder (MD) patients.
Barone, P   +16 more
core   +1 more source

A Dextral Primary Progressive Aphasia Patient with Right Dominant Hypometabolism and Tau Accumulation and Left Dominant Amyloid Accumulation

open access: yesCase Reports in Neurology, 2016
Background: Primary progressive aphasia (PPA) is a degenerative disease that presents as progressive decline of language ability with preservation of other cognitive functions in the early stages.
Young Kyoung Jang   +6 more
doaj   +1 more source

Advances in neuroimaging in frontotemporal dementia [PDF]

open access: yes, 2016
Frontotemporal dementia (FTD) is a clinically and neuroanatomically heterogeneous neurodegenerative disorder with multiple underlying genetic and pathological causes.
Fox, NC, Gordon, E, Rohrer, JD
core   +1 more source

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
This review outlines positron emission tomography (PET) biomarkers used in Alzheimer's disease (AD) research and clinical settings, targeting both specific (amyloid, tau) and non‐specific (neurodegeneration, synaptic density, neuroinflammation) processes.
Elif Harput   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy